Data is not available at this time.
MTI Ltd. operates as a specialized content distribution and digital healthcare solutions provider in Japan, leveraging mobile technology to serve diverse consumer and institutional needs. The company’s core revenue model revolves around subscription-based and transactional services, including Boshimo for childcare management, Luna-Luna for women’s healthcare, and Atleta for athlete-coach connectivity. These platforms cater to niche segments, positioning MTI as a hybrid player bridging healthcare, lifestyle, and fintech. Its &Pay service and AI-driven AMY solution further diversify revenue streams by addressing operational efficiency for businesses. MTI’s market position is reinforced by its focus on vertical integration, combining content, data management, and payment solutions under a unified ecosystem. While competing in Japan’s crowded digital services space, MTI differentiates through targeted applications like CARADA, which links health data across stakeholders, and music.jp, a multimedia store. The company’s ability to monetize both B2C and B2B segments provides resilience, though its reliance on domestic markets limits geographic diversification.
MTI reported revenue of JPY 27.7 billion for the period, with net income of JPY 2.36 billion, reflecting an 8.5% net margin. Operating cash flow stood at JPY 4.13 billion, significantly higher than capital expenditures of JPY -86 million, indicating strong cash generation from core operations. The company’s capital-light model is evident in its minimal capex requirements, supporting efficient resource allocation.
Diluted EPS of JPY 43.02 underscores MTI’s earnings capacity, driven by scalable digital platforms. The company’s operating cash flow-to-revenue ratio of 14.9% highlights effective conversion of sales into cash, while low debt levels (JPY 2.43 billion) relative to cash reserves (JPY 14.83 billion) suggest prudent capital management and room for strategic investments.
MTI maintains a robust balance sheet with JPY 14.83 billion in cash and equivalents, providing liquidity to fund growth initiatives. Total debt of JPY 2.43 billion is modest, resulting in a conservative net cash position. The absence of significant leverage and healthy cash reserves position the company to navigate market volatility without financial strain.
MTI’s growth is tied to adoption of its niche digital services, with potential upside from cross-selling across its ecosystem. The company pays a dividend of JPY 17 per share, yielding approximately 1.5% based on its current market cap, signaling a balanced approach between reinvestment and shareholder returns. Future expansion may hinge on scaling AI solutions like AMY or penetrating adjacent healthcare verticals.
With a market cap of JPY 46.3 billion, MTI trades at a P/E of ~19.6x, aligning with mid-cap tech-healthcare hybrids in Japan. The negative beta (-0.072) suggests low correlation to broader markets, possibly due to its specialized offerings. Investors likely price in steady growth from recurring revenue streams rather than hyper-scalability.
MTI’s strategic edge lies in its integrated digital ecosystem, combining healthcare, payments, and content. Near-term opportunities include monetizing data analytics from its platforms, while risks involve competition from larger tech firms. The outlook remains stable, supported by Japan’s aging population and digitalization trends, though international expansion could unlock incremental growth.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |